Search hospitals > Kentucky > Louisville
Jewish Hospital
Claim this profileLouisville, Kentucky 40202
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Heart Failure
Conducts research for Cancer
226 reported clinical trials
4 medical researchers
Summary
Jewish Hospital is a medical facility located in Louisville, Kentucky. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Heart Failure, Cancer and other specialties. Jewish Hospital is involved with conducting 226 clinical trials across 395 conditions. There are 4 research doctors associated with this hospital, such as Richard L. Deming, Mark Slaughter, MD, Mehmet S. Copur, and Narish Solankhi, M.D..Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage II
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Richard L. DemingMercy Medical Center - Des Moines6 years of reported clinical research
Expert in Breast Cancer
Expert in Cancer
178 reported clinical trials
242 drugs studied
Mark Slaughter, MDJewish Hospital5 years of reported clinical research
Studies Arrhythmia
Studies Cardiovascular Disease
4 reported clinical trials
6 drugs studied
Mehmet S. CopurBethesda North Hospital13 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
3 reported clinical trials
14 drugs studied
Narish Solankhi, M.D.Jewish Hospital3 years of reported clinical research
Studies Aortic Valve Stenosis
Studies Stenosis
1 reported clinical trial
2 drugs studied
Clinical Trials running at Jewish Hospital
Bladder Cancer
Lung Cancer
Bladder Carcinoma
Prostate Cancer
Testicular cancer
Multiple Myeloma
Melanoma
Cutaneous Melanoma
Kidney Cancer
Colon Cancer
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
Gemcitabine + Cisplatin
for Bladder Cancer
This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Recruiting1 award Phase 2
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting1 award Phase 221 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Jewish Hospital?
Jewish Hospital is a medical facility located in Louisville, Kentucky. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Heart Failure, Cancer and other specialties. Jewish Hospital is involved with conducting 226 clinical trials across 395 conditions. There are 4 research doctors associated with this hospital, such as Richard L. Deming, Mark Slaughter, MD, Mehmet S. Copur, and Narish Solankhi, M.D..
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.